New gene therapy trial aims to control hepatitis b virus
Disease control
Recruiting now
This early-stage study is testing a new gene therapy called CRMA-1001 in adults with chronic hepatitis B. The main goal is to check if the treatment is safe and how the body processes it, while also looking for early signs it might help control the virus. Participants will receiv…
Phase: PHASE1, PHASE2 • Sponsor: nChroma Bio • Aim: Disease control
Last updated Apr 16, 2026 12:47 UTC